Enanta Pharmaceuticals, Inc. (ENTA)

14.34 +0.04 (+0.24%) USD  |  NASDAQ  |  Mar 02, 10:29
More

Enanta Pharmaceuticals Other Income and Expenses (Quarterly)

Other Income and Expenses (Quarterly) Chart

View Other Income and Expenses (Quarterly) for ENTA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Income and Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Income and Expenses (Quarterly) Range, Past 5 Years

View Other Income and Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Income and Expenses (Quarterly) Benchmarks

View Other Income and Expenses (Quarterly) Benchmarks
Start Trial
Agios Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade